viewBed Bath & Beyond Inc.

Bed Bath & Beyond, FedEx, Adobe Systems and more - AFTER HOURS

Proactive takes a look at what was moving the market after hours in New York

Shares in Bed Bath & Beyond sank last night

US stocks closed higher on Tuesday but after the bell, shares in Bed Bath & Beyond Inc (NASDAQ:BBBY) took a bath as the firm reported sales that fell more than expected and offered a weak forward guidance.

Shares in the domestic merchandise group literally tanked 14.5% to US$23.10 in after-hours trade.

The retailer reported a same-store sales decrease of 2.6% after analysts had expected a decrease of 0.7%.

FedEx Corp (NYSE:FDX) shares dropped 1.39% after hours after the courier delivery group unveiled its first quarter earnings report.

The statement reflected the estimated negative impact Hurricane Harvey and the June 27 cyber attack affecting TNT Express.

“The first quarter posed significant operational challenges due to the TNT Express cyber-attack and Hurricane Harvey, and I want to thank our team members for their extraordinary dedication and performance,” said Frederick W. Smith, the firm's chairman and chief executive.

In tech, Adobe Systems Inc's (NASDAQ:ADBE) stock slipped 2.88% to US$152.09 in the extended session after the software company's results topped Wall Street estimates for the quarter.

Elsewhere, shares in medical device specialist Boston Scientific Corp (NYSE:BSX) reportedly added over 4% after hours after it announced positive late-breaking clinical trial data for a heart failure diagnostic.

The shares close on Wall Street on Tuesday 1.03% lower at $28.69 each.

Quick facts: Bed Bath & Beyond Inc.

Price: 14.2 USD

Market: NASDAQ
Market Cap: $1.79 billion

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Full interview: Preveceutical announces successful preliminary evaluation of...

Preveceutical (CSE:PREV-OTCQB: PRVCF) President Mak Jawadeker joined Steve Darling from Proactive Vancouver on Skype to discuss the company successfully completing the design, synthesis and preliminary evaluation of key peptides from its scorpion venom-derived peptide research and development...

3 hours, 33 minutes ago

2 min read